Potential role of human β-defensin 1 in Helicobacter pylori-induced gastritis

References

• Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest 2004; 113: 321–33
   PubMed Web of Science ®Google Scholar
• Nedrud JG, Blanchard SS, Czinn SJ. Helicobacter pylori inflammation and immunity. Helicobacter 2002; 7: 24–9
   PubMed Web of Science ®Google Scholar
• Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710–20
   PubMed Web of Science ®Google Scholar
• Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319–22
   PubMed Web of Science ®Google Scholar
• O'Neil DA, Cole SP, Martin-Porter E, Housley MP, Liu L, Ganz T, et al. Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000; 68: 5412–5
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschläger C, et al. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003; 56: 352–7
   PubMed Web of Science ®Google Scholar
• Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hojo H, et al. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001; 49: 481–7
   PubMed Web of Science ®Google Scholar
• Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, et al. Modulation of host antimicrobial peptide (β-defensins 1 and 2) expression during gastritis. Gut 2002; 51: 356–61
   PubMed Web of Science ®Google Scholar
• Vatta S, Boniotto M, Bevilacqua E, Belgrano A, Pirulli D, Crovella S, et al. Human beta defensin I gene: six new variants. Hum Mutat 2000; 15: 582–3
   PubMedGoogle Scholar
• Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2002; 29: 17–22
   Web of Science ®Google Scholar
• Levy H, Raby BA, Lake S, Tantisira KG, Kwiatkowski D, Lazarus R, et al. Association of defensin beta I gene polymorphisms with asthma. J Allergy Clin Immunol 2005; 115: 252–8
   PubMed Web of Science ®Google Scholar
• Vankeerberghen A, Scudiero O, De Boeck K, Macek M, Jr, Pignatti PF, Van Hul N, et al. Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations. Genomics 2005; 85: 574–81
   PubMed Web of Science ®Google Scholar
• Kocsis ÁK, Lakatos PL, Somogyvári F, Fuszek P, Papp J, Fischer S, et al. Association of beta-defensin 1 nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol 2007; 17: 1–9
   Google Scholar
• Sipponen P, Kekki M, Siurala M. The Sydney system: epidemiology and natural histrory of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244
   PubMed Web of Science ®Google Scholar
• Wallace AM, He J-Q, Burkett KM, Ruan J, Connett JE, Anthonisen NR, et al. Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study. Resp Res 2006; 7: 76–84
   PubMed Web of Science ®Google Scholar
• Naumann M, Crabtree J. Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol 2004; 12: 29–36
   PubMed Web of Science ®Google Scholar
• Tesse R, Cardinale F, Santostasi T, Polizzi A, Manca A, Mappa L, et al. Association of β-defensin-1 gene polymorphisms with Pseudomonas aeruginosa airway colonization in cystic fibrosis. Genes Immun 2008; 9: 57–60
   PubMed Web of Science ®Google Scholar
• Prado-Montes de Oca E, Garcia-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramirez L, Davalos-Rodriguez NO, et al. Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol 2007; 142: 211–8
   PubMed Web of Science ®Google Scholar
• Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human β-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41: 90–6
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Vignal C, Dessein R, Simonet M, Desreumaux P, Chamaillard M. NODs in defence: from vulnerable antimicrobial peptides to chronic inflammation. Trends Microbiol 2006; 14: 433–7
   Web of Science ®Google Scholar
• Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 reponds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166–74
   PubMed Web of Science ®Google Scholar
• Boughan PK, Argent RH, Body-Malapel M, Park J-H, Ewings KE, Bowie AG, et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor. J Biol Chem 2006; 281: 11637–48
   PubMed Web of Science ®Google Scholar